Indian drug companies start off a price war on experimental Covid-19 drug

Over the next few weeks, close to 10 drug companies including Abbott,
Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr
Reddy's Laboratories are expected to launch their own brands of
favipiravir, despite inconclusive evidence of its effectiveness.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-companies-start-off-a-price-war-on-experimental-covid-19-drug/articleshow/77156304.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny